Key Updates
Tesla shares declined -2.79% to $371.53 since the March 19 report, breaking below the critical $380 support level and accelerating YTD losses to -17.39%. The latest selloff was triggered by another delay in the next-generation Roadster unveiling to late April 2025, marking the latest postponement for a vehicle originally scheduled for 2020 production. This development reinforces concerns about capital allocation priorities as Tesla pivots resources toward robotaxis and AI chip manufacturing, while simultaneously discontinuing its premium Model S and Model X lines. The stock now trades at its lowest level in the current analysis period, having lost over 17% year-to-date amid mounting concerns about negative free cash flow and execution risks in multiple capital-intensive ventures.
Current Trend
Tesla shares are in a sustained downtrend, declining -17.39% YTD and breaking through multiple support levels. The stock has fallen -9.67% over the past month and -12.80% over six months, demonstrating consistent selling pressure across all timeframes. The $400 psychological level, which acted as resistance in the March 17 rally, remains 7.7% above current prices. The breakdown below $380 support has opened downside risk toward the $350-360 range, representing potential additional downside of 3-6%. Technical momentum remains firmly negative with lower highs and lower lows established across the 1-month, 6-month, and YTD timeframes, indicating sustained institutional distribution.
Investment Thesis
The investment thesis centers on Tesla's transformation from an automotive manufacturer to an AI and autonomous vehicle technology company, with analysts valuing the robotaxi and FSD businesses at $735 billion versus $345 billion for traditional EV operations. Bank of America's $460-488 price targets imply 24-31% upside potential, predicting Tesla will achieve $1.58 cost per mile for robotaxi services compared to $3.41 for traditional ride-sharing. However, this thesis faces significant execution risk as Tesla enters its most capital-intensive phase, with CapEx exceeding $20 billion in 2026 excluding the Terafab chip manufacturing facility, which could require up to $300 billion at full capacity. The company must simultaneously scale robotaxi operations from 2 cities to 9 by year-end, ramp third-generation Optimus robot production, and establish semiconductor manufacturing capabilities—all while Wall Street projects negative free cash flow of $4.1 billion in 2026 for the first time since 2018.
Thesis Status
The investment thesis is under increasing pressure as execution challenges mount across multiple fronts. The Roadster delay to late April 2025—the sixth postponement since the 2017 announcement—demonstrates continued difficulty in delivering premium products while managing competing priorities. The decision to discontinue Model S and Model X production this year removes high-margin revenue streams precisely when the company enters negative free cash flow territory. Most critically, only 1.1 million of 8.9 million Tesla vehicles sold have purchased FSD subscriptions (12.4% penetration), requiring aggressive growth to reach BofA's projection of 8.7 million FSD customers by 2030. The California regulatory settlement forcing removal of "Autopilot" marketing and the 14 crashes in Austin's robotaxi service since June highlight regulatory and safety headwinds. While analyst price targets suggest 24-31% upside, the thesis increasingly depends on flawless execution across AI chips, robotaxis, and humanoid robots—all unproven at scale—while traditional automotive operations deteriorate.
Key Drivers
The primary near-term catalyst is the Terafab Project launch in 7 days (March 23, 2026), Tesla's entry into logic and memory chip manufacturing to address AI chip supply constraints from TSMC, Samsung, and Micron. This initiative could require $30 billion initially and up to $300 billion at full capacity, representing unprecedented capital intensity for the company. Robotaxi expansion remains critical, with plans to expand from 2 cities currently to 9 by 2026, though 14 crashes in Austin since June raise safety concerns. The third-generation Optimus humanoid robot unveiling expected by end of March 2025 represents another value driver, with BofA valuing this segment at over $30 billion. Product portfolio shifts include discontinuation of Model S and Model X later this year to redirect capacity toward robotaxi production, which begins volume production next month. Regulatory dynamics remain fluid following California's acceptance of "Autopilot" removal from marketing to avoid sales license suspension.
Technical Analysis
Tesla exhibits a clear downtrend across all timeframes, with the stock declining -2.31% daily, -5.03% weekly, -9.67% monthly, and -17.39% YTD. The break below $380 support on March 19 has accelerated to $371.53, establishing a new lower low in the current cycle. Key resistance levels include $380 (former support, now resistance), $390 (broken on March 19), and $400 (psychological level tested unsuccessfully on March 17). Immediate support appears at $360-365, with a more significant support zone at $350. The stock has formed a series of lower highs at $399 (March 17), $390 (March 13), and now $382 (March 19), confirming bearish momentum. Volume patterns suggest institutional distribution, particularly on down days breaking support levels. The 6-month decline of -12.80% indicates this is not a short-term correction but a sustained re-rating of valuation multiples as the market prices in execution risk and negative free cash flow projections.
Bull Case
- Robotaxi market dominance potential: Bank of America values Tesla's autonomous vehicle and robotaxi businesses at $735 billion, more than double its $345 billion EV division, with projected cost per mile of $1.58 versus $3.41 for traditional ride-sharing, and Wall Street forecasting Tesla could capture up to 50% of the global robotaxi market with 5 million vehicles by 2035. Source
- Analyst price targets imply significant upside: Bank of America's $460-488 price targets represent 24-31% upside from current levels, with the firm resuming coverage with a buy rating and assigning 54% of Tesla's valuation to robotaxi business versus only 21% to core automotive operations. Source
- Cost-effective autonomous driving technology: Tesla's camera-only approach to autonomous driving is viewed as more cost-effective than competitors' multi-sensor systems, enabling more profitable scaling and establishing the company as the clear leader in autonomous driving technology. Source
- Diversified value creation beyond automotive: Additional value drivers include the Optimus humanoid robot segment valued at over $30 billion and the energy business valued at $90 billion, providing multiple paths to value creation beyond traditional vehicle sales. Source
- Vertical integration into AI chip manufacturing: The Terafab Project launching in 7 days addresses AI chip supply constraints and positions Tesla to control critical technology infrastructure, with the company targeting production of the AI5 chip for volume production in 2027 as current partners TSMC, Samsung, and Micron cannot meet future demand. Source
Bear Case
- Negative free cash flow for first time since 2018: Wall Street analysts predict Tesla's free cash flow will turn negative at -$4.1 billion in 2026 as the company enters its most capital-intensive expansion phase, with CapEx exceeding $20 billion excluding Terafab costs, which could reach $30 billion initially and potentially $300 billion at full capacity. Source
- Chronic product delays and execution risk: The Roadster has been delayed to late April 2025, marking another postponement for a vehicle originally announced in 2017 with production initially scheduled for 2020, demonstrating persistent inability to meet product timelines while managing competing priorities across robotaxis, AI chips, and humanoid robots. Source
- Low FSD adoption threatens autonomous strategy: Only 1.1 million of 8.9 million Tesla vehicles sold have purchased FSD subscriptions (12.4% penetration), requiring growth to 8.7 million customers by 2030 to meet BofA's projections, while regulatory approval remains uncertain in key markets including China and Europe. Source
- Safety and regulatory headwinds intensifying: Tesla's robotaxi service in Austin has experienced 14 crashes since launching in June, while California regulators forced removal of "Autopilot" marketing under threat of sales license suspension, and Germany's IG Metall union has accused Tesla of creating toxic work environment at its Berlin factory. Source
- Deteriorating core automotive business: Tesla is discontinuing its premium Model S and Model X lines later this year while facing a multiyear sales slump and declining EV demand following expiration of key tax credits, eliminating high-margin revenue streams precisely when the company needs cash flow to fund capital-intensive AI and robotaxi investments. Source